Activity of boanmycin against colorectal cancer

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

249

HTML

2119

Tables (1-4)

217

Sum=2585

Feb 15, 2001 (publication date) through Nov 27, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Feb 15, 2001; 7(1): 93-97
Published online Feb 15, 2001. doi: 10.3748/wjg.v7.i1.93

Table 1 Inhibitory effect of BAM on the growth of human colorectal xenografts in nude mice*

*Treatment was started on day 3 and day 14 after HT-29 and Hce-8693 tumor transplantation, ip., twice a week, with a total of 10 injections.

^bP < 0.01, vs control group.

Citation: Deng YC, Zhen YS, Zheng S, Xue YC. Activity of boanmycin against colorectal cancer. World J Gastroenterol 2001; 7(1): 93-97
URL: https://www.wjgnet.com/1007-9327/full/v7/i1/93.htm
DOI: https://dx.doi.org/10.3748/wjg.v7.i1.93